Evaluation of serum glucose-regulated protein 78 (GRP78) as a biomarker of treatment response to bortezomib-based induction regimen in multiple myeloma: A cross-sectional pilot studySuganthi S. Ramachandran, Yogendra Kumar Gupta|Neoplasma|2022Cited by 2